Market Cap 97.53M
Revenue (ttm) 0.00
Net Income (ttm) -89.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 604,100
Avg Vol 1,571,238
Day's Range N/A - N/A
Shares Out 69.17M
Stochastic %K 12%
Beta 1.93
Analysts Strong Sell
Price Target $10.14

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study....

Industry: Biotechnology
Sector: Healthcare
Phone: 781 797 0979
Address:
321 Harrison Avenue, 8th Floor, Boston, United States
Lanuchbox
Lanuchbox May. 29 at 11:36 AM
$PEPG Check out this really good video on what is happening here https://youtu.be/qSiABDoIPNg?si=uw5nYGQr3Owjl70T
0 · Reply
GangsterX
GangsterX May. 28 at 7:11 PM
$GERN $PMVP $PEPG slow Shixxx!! pathetic... i think it will move in June... Just hold
0 · Reply
Bebbz88
Bebbz88 May. 25 at 7:33 PM
$PEPG should be interesting this week leading up to presentation starting wednesday with actual data on thursday. Sounds promising the way they have worded it!
0 · Reply
GangsterX
GangsterX May. 22 at 4:14 PM
$PEPG holding big bag here.. shix... pathetic shix.. but that is okay.. it will go back up.... Cant lose on this one
1 · Reply
focafoca99
focafoca99 May. 21 at 11:44 AM
$PEPG updated its corporate presentation for the 15th International Myotonic Dystrophy Consortium.
0 · Reply
DARKP00L
DARKP00L May. 21 at 11:12 AM
$PEPG 07:04 on May. 21 2026 PepGen To Highlight Data From PGN-EDODM1 Program In Poster And Late-Breaking Oral Presentation At IDMC-15 #tradeideas
0 · Reply
Mike_Rotsch
Mike_Rotsch May. 19 at 10:01 PM
$PEPG " . . . from time to time", lol. To me, that translates to, "MASSIVE dilution is imminent, starting immediately."
0 · Reply
US4nr
US4nr May. 14 at 6:28 PM
$PEPG In at 1.64 for 10k shares. MOA looks good, data look good even if one single patients went the other way in the active, and safety signal is good. At this price it's a great bet, given the hold is nonsensical to me. Higher dose and more patients hopefully will strengthen the signal and minimize the variability among patients which is expected for some endpoints. This approach can work for DM2, too, which is an advantage over other modalities.
0 · Reply
anachartanalyst
anachartanalyst May. 13 at 3:02 PM
$PEPG https://anachart.com/wp-content/uploads/2026/05/1778684504_soc-img.jpg
0 · Reply
d_risk
d_risk May. 12 at 8:36 PM
$PEPG - PepGen Inc - 10Q - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +377.1% above peer average (55,820 vs 11,699 across 653 peers). PEPG’s 10-Q sharpens downside risk: it is now essentially a single‑asset, early‑stage biotech (PGN‑EDODM1 on partial FDA hold) with no revenue, escalating losses, heavy future financing needs, unproven platform, major safety and regulatory uncertainty, and a fragile, license‑dependent IP position vulnerable to challenges and enforcement failures. 🟢 Added 🟠 Removed https://d-risk.ai/PEPG/10-Q/2026-05-12
0 · Reply
Latest News on PEPG
PepGen files $400M mixed securities shelf

2026-05-19T16:10:09.000Z - 20 days ago

PepGen files $400M mixed securities shelf


PepGen Registration statement: Registration filing

May 18, 2026, 8:00 AM EDT - 21 days ago

PepGen Registration statement: Registration filing


PepGen price target lowered to $4 from $5 at Wedbush

2026-05-13T15:25:32.000Z - 26 days ago

PepGen price target lowered to $4 from $5 at Wedbush


PepGen reports Q1 EPS (26c), consensus (31c)

2026-05-12T21:47:50.000Z - 26 days ago

PepGen reports Q1 EPS (26c), consensus (31c)


PepGen sees cash runway into 2H27

2026-05-12T21:45:06.000Z - 26 days ago

PepGen sees cash runway into 2H27


PepGen Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 27 days ago

PepGen Quarterly report: Q1 2026


PepGen Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 27 days ago

PepGen Earnings release: Q1 2026


PepGen Slides: Company presentation

May 12, 2026, 7:00 AM EDT - 27 days ago

PepGen Slides: Company presentation


PepGen Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

PepGen Proxy statement: Proxy filing


PepGen Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

PepGen Proxy statement: Proxy filing


PepGen Slides: Company presentation

Apr 17, 2026, 7:00 AM EDT - 7 weeks ago

PepGen Slides: Company presentation


PepGen Transcript: Study update

Mar 31, 2026, 4:30 PM EDT - 2 months ago

PepGen Transcript: Study update


PepGen Press release: Study update

Mar 31, 2026, 4:30 PM EDT - 2 months ago

PepGen Press release: Study update


PepGen Slides: Study update

Mar 31, 2026, 4:30 PM EDT - 2 months ago

PepGen Slides: Study update


PepGen down 46% at $2.30 after Phase 2 Freedom trial data

2026-03-30T21:56:04.000Z - 2 months ago

PepGen down 46% at $2.30 after Phase 2 Freedom trial data


PepGen Inc trading resumes

2026-03-30T20:40:11.000Z - 2 months ago

PepGen Inc trading resumes


PepGen reports ‘promising’ topline results from MAD cohort

2026-03-30T20:20:05.000Z - 2 months ago

PepGen reports ‘promising’ topline results from MAD cohort


PepGen Inc trading halted, news pending

2026-03-30T20:07:54.000Z - 2 months ago

PepGen Inc trading halted, news pending


PepGen Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:00 PM EDT - 3 months ago

PepGen Transcript: Leerink Global Healthcare Conference 2026


PepGen Inc trading resumes

2026-03-04T21:39:13.000Z - 3 months ago

PepGen Inc trading resumes


PepGen reports Q4 EPS (27c), consensus (39c)

2026-03-04T21:19:21.000Z - 3 months ago

PepGen reports Q4 EPS (27c), consensus (39c)


PepGen Inc trading halted, news pending

2026-03-04T21:07:39.000Z - 3 months ago

PepGen Inc trading halted, news pending


PepGen Announces Regulatory Updates on FREEDOM2

Mar 4, 2026, 4:03 PM EST - 3 months ago

PepGen Announces Regulatory Updates on FREEDOM2


PepGen Annual report: Q4 2025

Mar 4, 2026, 4:00 PM EST - 3 months ago

PepGen Annual report: Q4 2025


PepGen Earnings release: Q4 2025

Mar 4, 2026, 4:00 PM EST - 3 months ago

PepGen Earnings release: Q4 2025


PepGen Slides: Company presentation

Mar 4, 2026, 7:00 AM EST - 3 months ago

PepGen Slides: Company presentation


Oppenheimer bullish on PepGen, initiates with an Outperform

2026-02-25T13:24:24.000Z - 3 months ago

Oppenheimer bullish on PepGen, initiates with an Outperform


PepGen price target raised to $7 from $6 at Guggenheim

2026-02-18T12:37:42.000Z - 3 months ago

PepGen price target raised to $7 from $6 at Guggenheim


PepGen Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 4:00 PM EST - 7 months ago

PepGen Transcript: Stifel 2025 Healthcare Conference


PepGen price target raised to $20 from $18 at H.C. Wainwright

2025-11-13T13:36:07.000Z - 7 months ago

PepGen price target raised to $20 from $18 at H.C. Wainwright


PepGen Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

PepGen Earnings release: Q3 2025


PepGen Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

PepGen Quarterly report: Q3 2025


PepGen Slides: Investor Presentation

Nov 11, 2025, 7:00 AM EST - 7 months ago

PepGen Slides: Investor Presentation


PepGen to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 7 months ago

PepGen to Participate in Upcoming Investor Conferences


PepGen Announces Pricing of $100 Million Public Offering

Sep 24, 2025, 10:51 PM EDT - 9 months ago

PepGen Announces Pricing of $100 Million Public Offering


PepGen Announces Proposed Public Offering

Sep 24, 2025, 4:21 PM EDT - 9 months ago

PepGen Announces Proposed Public Offering


PepGen Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 10 months ago

PepGen Earnings release: Q2 2025


PepGen Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 10 months ago

PepGen Quarterly report: Q2 2025


PepGen Slides: Corporate Presentation

Jun 17, 2025, 11:07 PM EDT - 1 year ago

PepGen Slides: Corporate Presentation


PepGen Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

PepGen Earnings release: Q1 2025


PepGen Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

PepGen Quarterly report: Q1 2025


PepGen Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PepGen Proxy statement: Proxy Filing


PepGen Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PepGen Proxy statement: Proxy Filing


Lanuchbox
Lanuchbox May. 29 at 11:36 AM
$PEPG Check out this really good video on what is happening here https://youtu.be/qSiABDoIPNg?si=uw5nYGQr3Owjl70T
0 · Reply
GangsterX
GangsterX May. 28 at 7:11 PM
$GERN $PMVP $PEPG slow Shixxx!! pathetic... i think it will move in June... Just hold
0 · Reply
Bebbz88
Bebbz88 May. 25 at 7:33 PM
$PEPG should be interesting this week leading up to presentation starting wednesday with actual data on thursday. Sounds promising the way they have worded it!
0 · Reply
GangsterX
GangsterX May. 22 at 4:14 PM
$PEPG holding big bag here.. shix... pathetic shix.. but that is okay.. it will go back up.... Cant lose on this one
1 · Reply
focafoca99
focafoca99 May. 21 at 11:44 AM
$PEPG updated its corporate presentation for the 15th International Myotonic Dystrophy Consortium.
0 · Reply
DARKP00L
DARKP00L May. 21 at 11:12 AM
$PEPG 07:04 on May. 21 2026 PepGen To Highlight Data From PGN-EDODM1 Program In Poster And Late-Breaking Oral Presentation At IDMC-15 #tradeideas
0 · Reply
Mike_Rotsch
Mike_Rotsch May. 19 at 10:01 PM
$PEPG " . . . from time to time", lol. To me, that translates to, "MASSIVE dilution is imminent, starting immediately."
0 · Reply
US4nr
US4nr May. 14 at 6:28 PM
$PEPG In at 1.64 for 10k shares. MOA looks good, data look good even if one single patients went the other way in the active, and safety signal is good. At this price it's a great bet, given the hold is nonsensical to me. Higher dose and more patients hopefully will strengthen the signal and minimize the variability among patients which is expected for some endpoints. This approach can work for DM2, too, which is an advantage over other modalities.
0 · Reply
anachartanalyst
anachartanalyst May. 13 at 3:02 PM
$PEPG https://anachart.com/wp-content/uploads/2026/05/1778684504_soc-img.jpg
0 · Reply
d_risk
d_risk May. 12 at 8:36 PM
$PEPG - PepGen Inc - 10Q - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +377.1% above peer average (55,820 vs 11,699 across 653 peers). PEPG’s 10-Q sharpens downside risk: it is now essentially a single‑asset, early‑stage biotech (PGN‑EDODM1 on partial FDA hold) with no revenue, escalating losses, heavy future financing needs, unproven platform, major safety and regulatory uncertainty, and a fragile, license‑dependent IP position vulnerable to challenges and enforcement failures. 🟢 Added 🟠 Removed https://d-risk.ai/PEPG/10-Q/2026-05-12
0 · Reply
GangsterX
GangsterX May. 12 at 6:14 PM
$GUTS $PEPG medium size bet baby.. still holding
0 · Reply
StockTone
StockTone May. 7 at 2:09 AM
$PEPG 👀
0 · Reply
GangsterX
GangsterX May. 6 at 6:04 PM
$PEPG Nice rebouncies... You can scare someone but u cant scare me baby.. U know me... Trading without fear.. if u know wat u doing, nothing to get scare shix
0 · Reply
GangsterX
GangsterX May. 6 at 5:05 PM
$PEPG Trading without fear, baby! That’s why my grandma tells me, “Don’t let fear control your money; it won’t make you money.” Bring it on, baby!
0 · Reply
GangsterX
GangsterX May. 6 at 4:55 PM
$PEPG added more at 1.70. If down to 1.50, i will add 3rd time. Watch and learn
0 · Reply
GangsterX
GangsterX May. 6 at 3:38 PM
$PEPG The sky is blue, My peanuts flew, Turbulence hit — Now they’re in row two
0 · Reply
GangsterX
GangsterX May. 6 at 3:30 PM
$PEPG Oh my buddha! i just loaded and i am down.. Wat da Heooo??
0 · Reply
GangsterX
GangsterX May. 6 at 2:40 PM
$PEPG This stock is good shix. If data in 2nd half 2026 good, it will be multi baggers here. I am willing to gamble at this price. Filled 1.87. Long term play.
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading May. 6 at 12:50 PM
🌅 Watchlist part 4 ✅ $AHMA 1.50 support, if above 2, have potential to 2.30/.50 ✅ $ATLN 1.10 support, if above 1.30, have potential to 1.50 ✅ $ALIT low 1 support, if above 1.20, have potential to 1.40/.60 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $PEPG $ENLV still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading May. 6 at 3:19 AM
🌅 Watchlist part 2 ✅ $EVC low 7 support, if above 7.55, has potential to 7.80/8 ✅ $EZGO low 3 support, if above 3.30, has potential to 3.50/.70 ✅ $CYPH still low volume, low 1.10 support, if above 1.30, has potential to 1.50/.60 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $PEPG $ENLV still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading May. 5 at 1:28 PM
🌅 Watchlist part 2 ✅ $SDOT 0.50 support, if above 0.60, has room to 0.70/0.75 ✅ $INHD low 2 support, if above 2.30, has room to 2.70/2.80 ✅ $GSUN still low volume, 0.50 support, if above 0.60, has room to 0.70/0.80 🚨 The above tickers are not ideal for swing accumulation at current price ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $PEPG $ENLV still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading May. 5 at 3:23 AM
🌅 Watchlist part 2 ✅ $BRCC low 1 support, if above 1.30, has room to 1.50/1.60 ✅ $DFSC still low volume, low 3 support, if above 3.40, has room to 3.60/3.80 ✅ $HOUR still low volume, 2.50 support, if above 2.70, has room to 3/3.50 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $PEPG $ENLV still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply